The Thrombin Mutant W215A/E217A Shows Safe and Potent Anticoagulant and Antithrombotic Effects in Vivo
Open Access
- 1 August 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (31) , 27581-27584
- https://doi.org/10.1074/jbc.c200237200
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Rational Design of a Potent Anticoagulant ThrombinJournal of Biological Chemistry, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Anticoagulant ThrombinsTrends in Cardiovascular Medicine, 1998
- The interface of atherosclerosis and thrombosis: basic mechanismsVascular Medicine, 1998
- Rational engineering of activity and specificity in a serine proteaseNature Biotechnology, 1997
- The thrombin paradoxNature, 1995
- Conversion of thrombin into an anticoagulant by protein engineeringNature, 1995
- Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.Journal of Clinical Investigation, 1993
- Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate modelBlood, 1989
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.Journal of Clinical Investigation, 1987